These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14987328)

  • 21. Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.
    Sung JJ; Mössner J; Barkun A; Kuipers EJ; Lau J; Jensen D; Stuart R; Junghard O; Olsson G;
    Aliment Pharmacol Ther; 2008 Apr; 27(8):666-77. PubMed ID: 18248654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
    N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis.
    Gené E; Sanchez-Delgado J; Calvet X; Gisbert JP; Azagra R
    Value Health; 2009; 12(5):759-62. PubMed ID: 19490560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
    Geus WP; Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding.
    Wang J; Yang K; Ma B; Tian J; Liu Y; Bai Z; Jiang L; Sun S; Li J; Liu R; Hao X; He X
    Can J Gastroenterol; 2009 Apr; 23(4):287-99. PubMed ID: 19373423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.
    Bardou M; Toubouti Y; Benhaberou-Brun D; Rahme E; Barkun AN
    Aliment Pharmacol Ther; 2005 Mar; 21(6):677-86. PubMed ID: 15771753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
    Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
    Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.
    Mabasa VH; Ma J
    J Manag Care Pharm; 2006 Jun; 12(5):371-6. PubMed ID: 16792443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care.
    Barkun AN; Crott R; Fallone CA; Kennedy WA; Lachaine J; Levinton C; Armstrong D; Chiba N; Thomson A; Veldhuyzen van Zanten S; Sinclair P; Escobedo S; Chakraborty B; Smyth S; White R; Kalra H; Nevin K
    Can J Gastroenterol; 2010 Aug; 24(8):489-98. PubMed ID: 20711528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies.
    Spiegel BM; Ofman JJ; Woods K; Vakil NB
    Am J Gastroenterol; 2003 Jan; 98(1):86-97. PubMed ID: 12526942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
    El-Serag HB; Graham DY; Richardson P; Inadomi JM
    Arch Intern Med; 2002 Oct; 162(18):2105-10. PubMed ID: 12374519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
    Triadafilopoulos G
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding.
    Hsu YC; Perng CL; Yang TH; Wang CS; Hsu WL; Wu HT; Cheng YC; Chiang MF; Lin HJ
    Br J Clin Pharmacol; 2010 Mar; 69(3):245-51. PubMed ID: 20233195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.